Bellerophon Therapeutics, Inc.
BLPH
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -61.28% | -35.23% | -24.14% | -72.01% | -60.59% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 44.67% | 119.07% | -53.03% | -62.26% | -62.36% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -73.27% | -73.45% | 293.20% | 293.20% | 292.23% |
| Total Current Assets | -58.71% | -33.81% | -23.13% | -70.29% | -59.42% |
|
|
|||||
| Total Current Assets | -58.71% | -33.81% | -23.13% | -70.29% | -59.42% |
| Net Property, Plant & Equipment | -- | -- | -98.79% | -80.00% | -67.41% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -61.73% | -61.73% | -61.73% |
| Total Assets | -60.51% | -36.58% | -26.58% | -70.47% | -59.74% |
|
|
|||||
| Total Accounts Payable | -59.87% | -5.98% | -51.21% | 3.19% | 19.33% |
| Total Accrued Expenses | -80.23% | 30.78% | 64.34% | 27.67% | 4.79% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -98.95% | -73.01% | -46.49% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -75.75% | 3.17% | -3.63% | 6.91% | 1.01% |
|
|
|||||
| Total Current Liabilities | -75.75% | 3.17% | -3.63% | 6.91% | 1.01% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 0.00% |
| Total Liabilities | -75.75% | 3.16% | -3.78% | 2.76% | -6.23% |
|
|
|||||
| Common Stock & APIC | 2.18% | 2.26% | 2.28% | 0.29% | 0.29% |
| Retained Earnings | -3.75% | -5.12% | -4.78% | -8.54% | -8.37% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -49.88% | -54.21% | -34.43% | -88.28% | -71.20% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -49.88% | -54.21% | -34.43% | -88.28% | -71.20% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -49.88% | -54.21% | -34.43% | -88.28% | -71.20% |
|
|
|||||
